Sumitomo Pharma Co., Ltd. (DNPUF)

Market Cap	5.83B +315.1%
Revenue (ttm)	2.89B +21.6%
Net Income	702.17M
EPS	1.77
Shares Out	n/a
PE Ratio	8.31
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	1,537
Open	12.88
Previous Close	n/a
Day's Range	12.88 - 12.88
52-Week Range	4.00 - 18.88
Beta	0.54
RSI	58.23
Earnings Date	Jan 30, 2026

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has coll...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1897
• Employees: 3,832
• Stock Exchange: OTCMKTS
• Ticker Symbol: DNPUF

Financial Performance

Financial numbers in JPY